HALO logo
halo search icon
BXPHARMA
Beximco Pharmaceuticals Plc

BXPHARMA · Beximco Pharmaceuticals Plc

151.10

BDT
-0.10 (-0.066%)
22/07/2026 12:00:00 AM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

Tk67.41B

PE

5.50

EV/EBITDA

3.9

DIV Yield

5.5%

Payout Ratio

31%

MQV Rating

5Very Weak

As at 22/07/2026 12:00:00 AM

Price Chart

Description

Beximco Pharmaceuticals PLC engages in the business of manufacturing and marketing generic pharmaceuticals formulation products covering a wide range of therapeutic categories. Its products include solid, liquid, cream, and ointment, suppositories, metered dose inhaler, dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company was founded by Ahmed Sohail Fasihur Rahman and Ahmed Salman Fasiur Rahman in 1976 and is headquartered in Dhaka, Bangladesh.

  • All-Companies
  • All-Consensus
  • Consensus Cheap
  • HALO 100
  • HALO 200
  • HALO 50
  • HALO All
  • HALO Earnings Momentum
  • HALO Momentum

Key Fundamentals

EPS 3 yr Growth

-0.10%

EBITDA Margin

23.30%

Operating Cashflow

£46m

Free Cash Flow Return

13.80%

ROIC

13.30%

Interest Coverage

17.40

Quick Ratio

1.10

Performance

52 weeks range

Low 99.5 - 158.5

Trade Value (12mth)

US$152,231.00

1 week

-2.77%

1 month

14.21%

YTD

48.28%

1 year

86.31%

All time high

255.40

Additional Data

Shares Outstanding (Fully Diluted)

446m

HALO Sector

Healthcare

Next Company Report Date

02-Sep-26

Next Ex Dividend Date

03-Aug-26

Next Dividend Pay Date

03-Aug-26

Reporting Currency

GBP

Short Sell (% of issue)

0.00

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Strong

Earnings

Very Strong

Growth

Earnings

Strong

Dividends

Neutral

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

No announcements available.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of Beximco Pharmaceuticals Plc (BXPHARMA:DHA)?
Halo FAQ
The current share price of Beximco Pharmaceuticals Plc (BXPHARMA:DHA) is BDT৳151.10.
2
What is the 52-week high share price for Beximco Pharmaceuticals Plc (BXPHARMA:DHA)?
Halo FAQ
The 52-week high share price for Beximco Pharmaceuticals Plc (BXPHARMA:DHA) is BDT৳158.50.
3
What is the 52-week low share price for Beximco Pharmaceuticals Plc (BXPHARMA:DHA)?
Halo FAQ
The 52-week low share price for Beximco Pharmaceuticals Plc (BXPHARMA:DHA) is BDT৳99.50.
4
What is the dividend yield for Beximco Pharmaceuticals Plc (BXPHARMA:DHA)?
Halo FAQ
The current TTM dividend payout for Beximco Pharmaceuticals Plc (BXPHARMA:DHA) is 5.50.
5
What was Beximco Pharmaceuticals Plc (BXPHARMA:DHA) last dividend payment?
Halo FAQ
The last dividend payment of Beximco Pharmaceuticals Plc (BXPHARMA:DHA) is BDT৳4.00.
6
What is the franking level for Beximco Pharmaceuticals Plc (BXPHARMA:DHA)?
Halo FAQ
Beximco Pharmaceuticals Plc (BXPHARMA:DHA) has a franking level of 0.00%.
7
In which sector is Beximco Pharmaceuticals Plc (BXPHARMA:DHA) classified?
Halo FAQ
Beximco Pharmaceuticals Plc (BXPHARMA:DHA) is classified in the Healthcare.
8
What is the price-to-earnings (P/E) ratio for Beximco Pharmaceuticals Plc (BXPHARMA:DHA)?
Halo FAQ
The current P/E ratio for Beximco Pharmaceuticals Plc (BXPHARMA:DHA) is 5.50.